Fherie Bernados 

Fherie Bernados is an analytical chemist with over 10 years of research and lab management experience. At REPS, he performs chemical analyses, develops purification assays, and designs and develops prototypes and finished product. His long term goal at REPS is to develop functional endocannabinoid health supplements that can be consumed using oral and inhalation delivery methods. Before REPS, he held positions within environmental science laboratories as an analytical chemist with a special interest in gas chromatographic techniques. Fherie received his Bachelor's degree in Chemistry from California State University - Sacramento.

Zach Bell 

The origins of REPS start with Zach Bell. In 2018 at OIST, he organized an international team of all PhD-level scientists to develop a disruptive platform technology called SEED-Tech. The technology was used to develop a performance supplement product and the intellectual property was transferred over to a Japanese startup that became REPS. Bell, now our CEO,  was trained as a Neuroscientist and has a strong interest in cognitive  performance enhancement. He aims to bridge the gap between academic biomedical science and the performance supplement industry, to stimulate innovation and technology development. He is also the Chief Science Officer of IONIC BRANDS Corp, a national cannabis holdings company based in Seattle, Washington USA; he has been with them since 2017. He received his PhD in Biology (Molecular Neuroscience) from Queen Mary University of London and two Bachelor's degrees (Biological Sciences and Human Performance) from the University of Memphis. He worked for OIST as a Postdoctoral Fellow and Entrepreneur in Residence, before spinning out REPS as a private company. He brings over 10 years of leadership and project management skills to REPS, and is passionate about advancing human performance through supplements.